| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2024 | 69 | 202,380 | ETR, AMGN, VZ, TXN | 13F-HR | 10/15/2024 | 000173121624000004 |
| Q2 2024 | 71 | 247,575 | UL, GD, AMGN, TXN | 13F-HR | 7/15/2024 | 000173121624000003 |
| Q1 2024 | 69 | 260 | MRK, GD, CFR, UL | 13F-HR | 4/5/2024 | 000173121624000002 |
| Q4 2023 | 70 | 245,307 | JPM, AMGN, CFR, GD | 13F-HR | 1/8/2024 | 000173121624000001 |
| Q3 2023 | 72 | 237,633 | JPM, UL, AMGN, MSM | 13F-HR | 10/13/2023 | 000173121623000005 |
| Q2 2023 | 72 | 246,281 | UL, JPM, MRK, JNJ | 13F-HR | 7/17/2023 | 000173121623000003 |
| Q1 2023 | 70 | 240,430 | UL, JPM, TXN, MRK | 13F-HR | 4/5/2023 | 000173121623000002 |
| Q4 2022 | 71 | 242,300 | PFE, UL, XOM, MRK | 13F-HR | 1/5/2023 | 000173121623000001 |
| Q3 2022 | 77 | 215,683 | PFE, UL, JNJ, XOM | 13F-HR | 10/6/2022 | 000173121622000004 |
| Q2 2022 | 71 | 210,764 | PFE, UL, JNJ, VZ | 13F-HR | 7/8/2022 | 000173121622000003 |
| Q1 2022 | 70 | 219,032 | CVX, PFE, JNJ, GD | 13F-HR | 4/6/2022 | 000173121622000002 |
| Q4 2021 | 69 | 211,842 | PFE, JPM, CSCO, TXN | 13F-HR | 1/6/2022 | 000173121622000001 |
| Q3 2021 | 68 | 198,006 | PFE, JPM, USB, INTC | 13F-HR | 10/6/2021 | 000173121621000004 |
| Q2 2021 | 68 | 197,229 | JPM, PFE, TXN, USB | 13F-HR | 7/6/2021 | 000173121621000003 |
| Q1 2021 | 69 | 188,392 | JPM, PFE, TXN, USB | 13F-HR | 4/14/2021 | 000173121621000002 |
| Q4 2020 | 67 | 171,127 | TXN, PFE, JPM, JNJ | 13F-HR | 1/7/2021 | 000173121621000001 |
| Q3 2020 | 63 | 149,500 | UPS, PFE, AMGN, TXN | 13F-HR | 10/8/2020 | 000173121620000005 |
| Q2 2020 | 60 | 142,158 | PFE, UPS, AMGN, JNJ | 13F-HR | 7/7/2020 | 000173121620000004 |
| Q1 2020 | 58 | 131,272 | PFE, JNJ, AMGN, UPS | 13F-HR | 4/21/2020 | 000173121620000003 |
| Q4 2019 | 62 | 169,199 | PFE, JPM, JNJ, AMGN | 13F-HR | 1/31/2020 | 000173121620000001 |
| Q3 2019 | 53 | 148,583 | PFE, JNJ, GSK, JPM | 13F-HR | 11/20/2019 | 000173121619000004 |
| Q2 2019 | 50 | 141,354 | PFE, JNJ, CSCO, SBUX | 13F-HR | 8/12/2019 | 000173121619000003 |
| Q1 2019 | 61 | 129,547 | PFE, JNJ, CSCO, GSK | 13F-HR | 5/8/2019 | 000173121619000002 |
| Q4 2018 | 49 | 108,360 | PFE, SBUX, JNJ, PG | 13F-HR | 2/14/2019 | 000173121619000001 |
| Q3 2018 | 58 | 111,624 | PFE, JNJ, AAPL, CSCO | 13F-HR | 11/14/2018 | 000173121618000006 |
| Q2 2018 | 45 | 97,883 | PFE, JNJ, GSK, RDS.B | 13F-HR | 8/13/2018 | 000173121618000005 |
| Q1 2018 | 44 | 100,452 | CSCO, PFE, JNJ, GSK | 13F-HR | 5/14/2018 | 000173121618000002 |
| Q4 2017 | 44 | 96,343 | JNJ, CSCO, PFE, BA | 13F-HR | 2/13/2018 | 000173121618000001 |